The clonal hematopoietic stem cell disease known as chronic myeloid leukemia (CML) is characterized by oncogenic breakpoint cluster region–Abelson (BCR–ABL1) gene fusion. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.